Should Initiators reach out to existing vendors to invite them onboard? No, not at this time. We currently have all of the information to make payments to these vendors. We will develop a process for ...

With spironolactone (Aldactone) treatment for acne rising several-fold in recent decades, safety concerns persist for this off-label practice in understudied populations. A database of U.S. insurance ...

At 12 months, 25.1% of patients starting tofacitinib and 30.1% of TNF inhibitor initiators achieved low disease activity. Tofacitinib and TNF inhibitors are common options when methotrexate proves ...